Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

An Interview With Brian Morrissey
In this interview we spoke to Brian Morrissey, General Manager of Gaelic Laboratories, about the strategy behind their acquisition of Athlone Laboratories, and its impact. read more
How Real-Time Data Analytics Can Address Common Pain Points in Clinical Trials
Major issues in clinical oversight are latency and heterogeneity across systems including formats, identifiers, coding conventions, and timing of updates. read more
Five Steps to Smooth Agentic AI Adoption
In agentic AI-enabled labs, AI goes from individual, one-off applications to comprehensive workflow orchestration. read more
Horizon Lines: A Quarterly Review of NDAs – January-March, 2026
The NDAs approved during the first quarter of 2026 have been divided into the dosage forms Injection, Tablets, Capsules, Oral solution, Gas, and other. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Hovione Names Chairman Stefan Doboczky as CEO
Tuesday, September 08, 2026
Hovione Holding AG has appointed Stefan Doboczky as chief executive officer, effective April 1, 2027, moving the company’s current board chairman into... read more
AtomVie Opens $160M Radiopharmaceutical CDMO Facility in Hamilton
Tuesday, September 08, 2026
AtomVie Global Radiopharma has opened a new radiopharmaceutical manufacturing facility in Hamilton, Ontario, following an investment of more than $160... read more
Charles River Automates Endosafe Cartridge Production
Tuesday, September 08, 2026
Charles River Laboratories has brought a fully automated production suite for Endosafe bacterial endotoxin testing cartridges into full operation, ... read more
Onyx Scientific Invests $2 Million in UK API Manufacturing Expansion
Tuesday, September 08, 2026
Onyx Scientific will invest more than £1.5 million, or about $2 million, to expand commercial active pharmaceutical ingredient manufacturing capacity ... read more
Lifecore Adds Seventh Late-Stage Commercial Manufacturing Program
Thursday, September 03, 2026
Lifecore Biomedical has signed an agreement with an undisclosed global pharmaceutical company to transfer manufacturing of a currently marketed ... read more